United States · FDA National Drug Code directory
Solifenacin Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-879_ececaabb-2b01-4ef5-b5e8-a927478deccc
- Product NDC
- 65862-879
- Form
- TABLET, FILM COATED
- Composition / generic term
- Solifenacin Succinate
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221227
- Source listing expiry
- 20261231
Source-listed ingredients
- SOLIFENACIN SUCCINATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (65862-879-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-879-10) · 65862-879-03
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-879-30) · 65862-879-30
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-879-90) · 65862-879-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-879-99) · 65862-879-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →